Arima Genomics Partners with Active Motif for Hi-C Research Distribution
CARLSBAD, Calif., July 2, 2026 Arima Genomics, Inc. announced an exclusive distribution partnership with Active Motif Incorporated, granting the...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CARLSBAD, Calif., July 2, 2026 Arima Genomics, Inc. announced an exclusive distribution partnership with Active Motif Incorporated, granting the...
VANCOUVER, BC — December 5, 2025 — TempraMed Technologies Ltd. announced a major expansion into Western Europe through a...
